NCT01333904View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

PUR118

inhaled

Trial Locations (1)

NG11 6JS

Quotient Bioresearch, Nottingham

Sponsors

Collaborators (1)

Quotient Bioresearch
All Listed Sponsors
collaborator

Quotient Bioresearch

INDUSTRY

lead

Pulmatrix Inc.

INDUSTRY